Stephan MÄRSCH

Person

Koln, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,643,469
- Issue date May 9, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody drug conjugates (ADCs) having KSP inhibitors
- Patent number 11,433,140
- Issue date Sep 6, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 11,071,788
- Issue date Jul 27, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,001,636
- Issue date May 11, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 10,744,205
- Issue date Aug 18, 2020
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL...
- Publication number 20240317847
- Publication date Sep 26, 2024
- Bayer Aktiengesellschaft
- Maik Stefan Wilhelm OBENDORF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL...
- Publication number 20240124572
- Publication date Apr 18, 2024
- Bayer Aktiengesellschaft
- Maik Stefan Wilhelm OBENDORF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20230399411
- Publication date Dec 14, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20220362392
- Publication date Nov 17, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20220267457
- Publication date Aug 25, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...
- Publication number 20210275686
- Publication date Sep 9, 2021
- Bayer Aktiengesellschaft
- Sarah Anna Liesa JOHANNES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20210230284
- Publication date Jul 29, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20200138970
- Publication date May 7, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20190365916
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20190330357
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318438
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318437
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180185510
- Publication date Jul 5, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stephan MÄRSCH

Person

Patents Grantslast 30 patents

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Specific antibody drug conjugates (ADCs) having KSP inhibitors

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Patents Applicationslast 30 patents

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL...

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL...

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...